ANDA Approval by US FDA
Awaiting price reaction for this filing.
J.B. Chemicals & Pharmaceuticals has received approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Bisoprolol Tablets USP in 5 mg and 10 mg strengths. This is the generic version of Teva's Zebeta, which is used for managing hypertension. The approval allows the company to manufacture and market this generic drug in the US market. This adds to the company's portfolio of US-approved generic products, which is a key growth driver for pharma companies.
Positive for the company as it opens a new revenue stream from the US generic market for a chronic-use hypertension drug. Approval of ANDAs typically supports long-term export earnings, though immediate revenue impact depends on launch timing and competition.